Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Digoxin, Fruquintinib, and Tislelizumab in advanced CRC
NCT07025850Phase 2Not yet recruiting
- Sponsor
- Fudan University
- Start
- Aug 2025
- Primary completion
- Jan 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of digoxin in colorectal cancer (CRC), sponsored by Fudan University. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
digoxin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT07025850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07025850.